BTAI vs NUE · rev $388.0K vs P/E 25, rev $19.89B
BioXcel Therapeutics Inc (BTAI) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
BTAI currently screens at market cap $36.1M. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the BTAI and NUE stock pages for the full models.
Not investment advice.